Gender difference in bone metastasis of human small cell lung cancer, SBC-5 cells in natural killer-cell depleted severe combined immunodeficient mice.
Lung cancer frequently develops multiple organ metastases, which thus makes this disease a leading cause of malignancy-related death worldwide. A gender difference is reported to affect the incidence and mortality of lung cancer; however, whether and how the gender difference is involved in lung cancer metastasis is unclear. This study evaluated the gender difference in multiple organ metastases in human small cell lung cancer (SBC-5) cells by using natural killer cell-depleted severe combined immunodeficient mice. Among multiple organ metastases, only bone metastasis formation significantly increased in female mice in comparison to males, while no significant difference was observed in the metastases to the liver and lungs. The suppression of androgen by castration or androgen receptor antagonist treatment in male mice also induced a significant increase of bone metastases. The number of osteoclasts in the bone metastatic lesions was greater in female mice and in mice with androgen suppression than in control male. However, there was no significant difference in the serum concentration of parathyroid hormone-related protein (PTHrP) associated with gender or androgen suppression. An in vitro study also indicated that sex steroid treatment had no effect on the proliferation or PTHrP production in SBC-5 cells. These results indicate that the balance of sex steroids therefore plays an important role in the formation of bone metastasis in small cell lung cancer, and suggests diverse mechanisms of interaction between cancer cells and host cells in the bone microenvironment.
Sakaguchi
Satoshi
S
Department of Respiratory Medicine and Rheumatology, Institute of Health Biosciences, The University of Tokushima Gradate School, 3-18-15 Kuramoto-cho Tokushima, Tokushima, 770-8503, Japan.
Goto
Hisatsugu
H
Hanibuchi
Masaki
M
Otsuka
Shinsaku
S
Ogino
Hirokazu
H
Kakiuchi
Soji
S
Uehara
Hisanori
H
Yano
Seiji
S
Nishioka
Yasuhiko
Y
Sone
Saburo
S
D000728:Androgens / Q000502:physiology; D000818:Animals; D001483:Base Sequence; D001859:Bone Neoplasms / Q000276:immunology / Q000556:secondary*; D018288:Carcinoma, Small Cell / Q000276:immunology / Q000473:pathology*; D045744:Cell Line, Tumor; D049109:Cell Proliferation; D017931:DNA Primers; D005260:Female; D006801:Humans; D007694:Killer Cells, Natural / Q000276:immunology*; D008175:Lung Neoplasms / Q000276:immunology / Q000473:pathology*; D008297:Male; D051379:Mice; D016513:Mice, SCID; D009919:Orchiectomy; D044162:Parathyroid Hormone-Related Protein / Q000097:blood; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012737:Sex Factors
D000728:Androgens; D017931:DNA Primers; D044162:Parathyroid Hormone-Related Protein
Osteoporos Int. 2008 Mar;19(3):321-7
17906826
J Steroid Biochem Mol Biol. 2007 Jan;103(1):76-83
17049844
Int J Cancer. 2004 Feb 10;108(4):511-5
14696114
Cancer Metastasis Rev. 2007 Dec;26(3-4):685-9
17786536
Lung Cancer. 2008 Jul;61(1):73-81
18243402
Proc Natl Acad Sci U S A. 1996 Dec 24;93(26):15152-7
8986779
Br J Cancer. 2005 May 23;92(10):1877-80
15870715
Bone. 2006 Feb;38(2):220-6
16213803
J Clin Invest. 1995 Jun;95(6):2886-95
7769130
Endocrinology. 2003 Mar;144(3):858-67
12586762
Cancer. 1997 Oct 15;80(8 Suppl):1588-94
9362426
J Thorac Oncol. 2009 Jan;4(1):37-43
19096304
Int J Cancer. 1999 Oct 8;83(2):278-82
10471539
Cancer Res. 2008 Apr 1;68(7):2275-85
18381434
Cancer. 2007 Sep 15;110(6):1313-20
17676588
Clin Cancer Res. 2008 Oct 15;14(20):6387-95
18927277
Clin Cancer Res. 2008 Jul 15;14(14):4417-26
18579664
Cancer Metastasis Rev. 2006 Dec;25(4):551-8
17160558
J Thorac Oncol. 2008 Jan;3(1):46-52
18166840
Cancer. 2003 Feb 1;97(3 Suppl):719-25
12548568
Gastroenterol Jpn. 1989 Apr;24(2):127-34
2545498
Clin Calcium. 2008 Apr;18(4):455-9
18379026
Biochem Biophys Res Commun. 1998 Oct 29;251(3):849-54
9790998
Endocrinology. 2005 Jul;146(7):2885-94
15831570
J Natl Cancer Inst. 2008 Dec 3;100(23):1672-94
19033571